The first classification on this topic categorized cardiomyopathies as heart muscle diseases
with dilated (DCM), hypertrophic, restrictive, arrhythmogenic right ventricular (ARVC), or …

Objective To perform a systematic review of the literature regarding the epidemiology of the
association between systemic lupus erythematosus (SLE) and atherosclerotic …

Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia (SBC),
acompanhando o amplo cenário de publicações científicas sobre o tratamento das …

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can involve any
organ system, and may lead to significant morbidity and even mortality. This article reviews …

Nervous system involvement in systemic lupus erythematosus (SLE) can manifest as a
range of neurological and psychiatric features, which are classified using the ACR case …

The excess risk of cardiovascular disease (CVD) associated with inflammatory rheumatic
diseases has long been recognized. Patients with established rheumatoid arthritis (RA) or …

1408 Circulation October 14, 2014 changes from the first to second decade, progressing
with age. 10, 11 Advanced atherosclerotic lesions are almost nonexistent up to the fourth …

Antiphospholipid Syndrome (APS) is characterized by vascular thrombosis and/or
pregnancy morbidity occurring in patients with persistent antiphospholipid antibodies (aPL) …

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that affects
various organs. Lupus nephritis is one of the most common, and most important, serious …

Background Data on long-term cardiovascular outcomes in systemic lupus erythematosus
(SLE) are sparse. Objectives This study sought to examine the long-term risk and prognosis …